{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:23:51Z","timestamp":1787027031450,"version":"build-2736575974"},"reference-count":101,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T00:00:00Z","timestamp":1656288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Post-traumatic stress disorder (PTSD), a common condition with potentially devastating individual, family, and societal consequences, is highly associated with substance use disorders (SUDs). The association between PTSD and SUD is complex and may involve adverse childhood experiences (ACEs), historical and multi-generational traumas, and social determinants of health as well as cultural and spiritual contexts. Current psychosocial and pharmacological treatments for PTSD are only modestly effective, and there is a need for more research on therapeutic interventions for co-occurring PTSD and SUD, including whether to provide integrated or sequential treatments. There is a current resurgence of interest in psychedelics as potential treatment augmentation for PTSD and SUDs with an appreciation of the risks in this target population. This paper reviews the historical perspective of psychedelic research and practices, as well as the intersection of historical trauma, ACEs, PTSD, and SUDs through the lens of New Mexico. New Mexico is a state with high populations of Indigenous and Hispanic peoples as well as high rates of trauma, PTSD, and SUDs. Researchers in New Mexico have been leaders in psychedelic research. Future directions for psychedelic researchers to consider are discussed, including the importance of community-based participatory approaches that are more inclusive and respectful of Indigenous and other minority communities.<\/jats:p>","DOI":"10.3389\/fphar.2022.905753","type":"journal-article","created":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T02:01:55Z","timestamp":1656295315000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Psychedelic Therapies at the Crossroads of Trauma and Substance Use: Historical Perspectives and Future Directions, Taking a Lead From New Mexico"],"prefix":"10.3389","volume":"13","author":[{"given":"Snehal R.","family":"Bhatt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tassy","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Maviglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Kass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Leeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Romo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Ziedonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1021\/acsptsci.1c00018","article-title":"Naturalistic Use of Mescaline Is Associated with Self-Reported Psychiatric Improvements and Enduring Positive Life Changes","volume":"4","author":"Agin-Liebes","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"100538","DOI":"10.1016\/j.eclinm.2020.100538","article-title":"Psilocybin-assisted Group Therapy for Demoralized Older Long-Term AIDS Survivor Men: An Open-Label Safety and Feasibility Pilot Study","volume":"27","author":"Anderson","year":"2020","journal-title":"EClinicalMedicine"},{"key":"B3","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1080\/10826084.2021.1887249","article-title":"The Joint Effect of Childhood Abuse and Homelessness on Substance Use in Adulthood","volume":"56","author":"Ararso","year":"2021","journal-title":"Subst. Use Misuse"},{"key":"B4","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1111\/dar.12985","article-title":"Exploring Ayahuasca-Assisted Therapy for Addiction: A Qualitative Analysis of Preliminary Findings Among an Indigenous Community in Canada","volume":"38","author":"Argento","year":"2019","journal-title":"Drug Alcohol Rev."},{"key":"B5","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1176\/appi.focus.16408","article-title":"VA\/DOD Clinical Practice Guideline for the Management of Posttraumatic Stress Disorder and Acute Stress Disorder: Clinician Summary","volume":"16","year":"2017","journal-title":"Focus (Am Psychiatr. Publ."},{"key":"B6","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1080\/00952990.2020.1808982","article-title":"Ketamine-facilitated Behavioral Treatment for Cannabis Use Disorder: a Proof of Concept Study","volume":"47","author":"Azhari","year":"2021","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"B7","unstructured":"BaezW. A. L. L.\n          Sociology ETDs: University of New MexicoHispanos in the Valley of Death: Street-Level Trauma, Cultural-Post Traumatic Stress Disorder, Overdoses, and Suicides in North Central New Mexico2012"},{"key":"B8","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/02791072.2009.10400530","article-title":"A Six-Month Prospective Evaluation of Personality Traits, Psychiatric Symptoms and Quality of Life in Ayahuasca-Na\u00efve Subjects","volume":"41","author":"Barbosa","year":"2009","journal-title":"J. Psychoact. Drugs"},{"key":"B9","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/dta.1383","article-title":"Health Status of Ayahuasca Users","volume":"4","author":"Barbosa","year":"2012","journal-title":"Drug Test. Anal."},{"key":"B10","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.comppsych.2016.09.003","article-title":"Psychological and Neuropsychological Assessment of Regular Hoasca Users","volume":"71","author":"Barbosa","year":"2016","journal-title":"Compr. Psychiatry"},{"key":"B11","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3389\/fpsyt.2018.00136","article-title":"Assessment of Alcohol and Tobacco Use Disorders Among Religious Users of Ayahuasca","volume":"9","author":"Barbosa","year":"2018","journal-title":"Front. Psychiatry"},{"key":"B12","doi-asserted-by":"publisher","first-page":"h6161","DOI":"10.1136\/bmj.h6161","article-title":"Post-traumatic Stress Disorder","volume":"351","author":"Bisson","year":"2015","journal-title":"Bmj"},{"key":"B13","doi-asserted-by":"publisher","first-page":"CD003388","DOI":"10.1002\/14651858.CD003388.pub4","article-title":"Psychological Therapies for Chronic Post-traumatic Stress Disorder (PTSD) in Adults","volume":"2013","author":"Bisson","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"B14","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/ADM.0000000000000400","article-title":"Gaps in the Substance Use Disorder Treatment Referral Process: Provider Perceptions","volume":"12","author":"Blevins","year":"2018","journal-title":"J. Addict. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3109\/15563657708988210","article-title":"Peyote, a Potential Ethnopharmacologic Agent for Alcoholism and Other Drug Dependencies: Possible Biochemical Rationale","volume":"11","author":"Blum","year":"1977","journal-title":"Clin. Toxicol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1177\/0269881114565144","article-title":"Psilocybin-assisted Treatment for Alcohol Dependence: a Proof-Of-Concept Study","volume":"29","author":"Bogenschutz","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e42421","DOI":"10.1371\/journal.pone.0042421","article-title":"Personality, Psychopathology, Life Attitudes and Neuropsychological Performance Among Ritual Users of Ayahuasca: a Longitudinal Study","volume":"7","author":"Bouso","year":"2012","journal-title":"PLoS One"},{"key":"B18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/02791072.2003.10399988","article-title":"The Historical Trauma Response Among Natives and its Relationship with Substance Abuse: A Lakota Illustration","volume":"35","author":"Brave Heart","year":"2003","journal-title":"J. Psychoact. Drugs"},{"key":"B19","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1177\/0269881120959637","article-title":"Pivotal Mental States","volume":"35","author":"Brouwer","year":"2020","journal-title":"J. Psychopharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/02791072.2019.1598603","article-title":"Ibogaine and Subjective Experience: Transformative States and Psychopharmacotherapy in the Treatment of Opioid Use Disorder","volume":"51","author":"Brown","year":"2019","journal-title":"J. Psychoact. Drugs"},{"key":"B21","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1037\/a0025668","article-title":"Increasing Ethnic Minority Participation in Substance Abuse Clinical Trials: Lessons Learned in the National Institute on Drug Abuse's Clinical Trials Network","volume":"17","author":"Burlew","year":"2011","journal-title":"Cultur. Divers Ethn. Minor Psychol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.amepre.2015.07.022","article-title":"Associations between Adverse Childhood Experiences, High-Risk Behaviors, and Morbidity in Adulthood","volume":"50","author":"Campbell","year":"2016","journal-title":"Am. J. Prev. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/HRP.0000000000000186","article-title":"Evidenced-based Treatment of Posttraumatic Stress Disorder: An Updated Review of Validated Psychotherapeutic and Pharmacological Approaches","volume":"26","author":"Charney","year":"2018","journal-title":"Harv Rev. Psychiatry"},{"key":"B24","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1176\/appi.ajp.2019.19070684","article-title":"A Single Ketamine Infusion Combined with Motivational Enhancement Therapy for Alcohol Use Disorder: a Randomized Midazolam-Controlled Pilot Trial","volume":"177","author":"Dakwar","year":"2020","journal-title":"Am. J. Psychiatry"},{"key":"B25","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1176\/appi.ajp.2019.18101123","article-title":"A Single Ketamine Infusion Combined with Mindfulness-Based Behavioral Modification to Treat Cocaine Dependence: a Randomized Clinical Trial","volume":"176","author":"Dakwar","year":"2019","journal-title":"Am. J. Psychiatry"},{"key":"B26","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1177\/0269881120967878","article-title":"Development of the Psychological Insight Questionnaire Among a Sample of People Who Have Consumed Psilocybin or LSD","volume":"35","author":"Davis","year":"2021","journal-title":"J. Psychopharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1108\/jpmh-01-2014-0003","article-title":"Clinical Trials and American Indians\/Alaska Natives with Substance Use Disorders: Identifying Potential Strategies for a New Cultural-Based Intervention","volume":"13","author":"Dickerson","year":"2014","journal-title":"J. Public Ment. Health"},{"key":"B28","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jep.2005.04.022","article-title":"Prehistoric Peyote Use: Alkaloid Analysis and Radiocarbon Dating of Archaeological Specimens of Lophophora from Texas","volume":"101","author":"El-Seedi","year":"2005","journal-title":"J. Ethnopharmacol."},{"key":"B29","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.drugalcdep.2010.03.024","article-title":"Assessment of Addiction Severity Among Ritual Users of Ayahuasca","volume":"111","author":"F\u00e1bregas","year":"2010","journal-title":"Drug alcohol dependence"},{"key":"B30","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1001\/jamapsychiatry.2014.62","article-title":"Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder: a Randomized Clinical Trial","volume":"71","author":"Feder","year":"2014","journal-title":"JAMA psychiatry"},{"key":"B31","doi-asserted-by":"publisher","first-page":"650","DOI":"10.3389\/fpsyt.2019.00650","article-title":"Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline","volume":"10","author":"Feduccia","year":"2019","journal-title":"Front. Psychiatry"},{"key":"B32","first-page":"31","article-title":"Adverse Childhood Experiences and Health Outcomes in Adults: The Ace Study","volume":"90","author":"Felitti","year":"1998","journal-title":"J. Fam. Consumer Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11920-016-0709-y","article-title":"Concurrent Treatment of Substance Use and PTSD","volume":"18","author":"Flanagan","year":"2016","journal-title":"Curr. psychiatry Rep."},{"key":"B34","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1556\/2054.2019.031","article-title":"The Role of Indigenous Knowledges in Psychedelic Science","volume":"4","author":"Fotiou","year":"2020","journal-title":"J. Psychedelic Stud."},{"key":"B35","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1111\/j.1360-0443.2004.00744.x","article-title":"Comparison of Acute Lethal Toxicity of Commonly Abused Psychoactive Substances","volume":"99","author":"Gable","year":"2004","journal-title":"Addiction"},{"key":"B36","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1556\/2054.2019.015","article-title":"The Psychedelic Renaissance and the Limitations of a White-dominant Medical Framework: A Call for Indigenous and Ethnic Minority Inclusion","volume":"4","author":"George","year":"2020","journal-title":"J. Psychedelic Stud."},{"key":"B37","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1021\/acsptsci.0c00171","article-title":"Ethical Concerns about Psilocybin Intellectual Property","volume":"4","author":"Gerber","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1177\/1049732312450324","article-title":"\"We're Still in a Struggle\": Din\u00e9 Resilience, Survival, Historical Trauma, and Healing","volume":"22","author":"Goodkind","year":"2012","journal-title":"Qual. Health Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3109\/00952990.2012.702170","article-title":"Review of Substance Use Disorder Treatment Research in Indian Country: Future Directions to Strive toward Health Equity","volume":"38","author":"Greenfield","year":"2012","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"B40","unstructured":"A Conversation with Psychedelic Pioneer\n            GreerG.\n          2020"},{"key":"B41","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1080\/02791072.1986.10472364","article-title":"Subjective Reports of the Effects of MDMA in a Clinical Setting","volume":"18","author":"Greer","year":"1986","journal-title":"J. Psychoact. Drugs"},{"key":"B42","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1177\/0269881108094300","article-title":"Mystical-type Experiences Occasioned by Psilocybin Mediate the Attribution of Personal Meaning and Spiritual Significance 14 Months Later","volume":"22","author":"Griffiths","year":"2008","journal-title":"J. Psychopharmacol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.biopsych.2005.06.038","article-title":"Psychological and Cognitive Effects of Long-Term Peyote Use Among Native Americans","volume":"58","author":"Halpern","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1111\/add.15789","article-title":"Mental Health Conditions and Receipt of Mental Health Care by Illicit Lysergic Acid Diethylamide (LSD) Use Status Among Young Adults in the United States","volume":"117","author":"Han","year":"2022","journal-title":"Addiction"},{"key":"B45","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1377\/hlthaff.2019.00309","article-title":"Gaps in Access to Opioid Use Disorder Treatment for Medicare Beneficiaries","volume":"39","author":"Harris","year":"2020","journal-title":"Health Aff. (Millwood)"},{"key":"B46","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1080\/02791072.2011.628913","article-title":"Historical Trauma Among Indigenous Peoples of the Americas: Concepts, Research, and Clinical Considerations","volume":"43","author":"Heart","year":"2011","journal-title":"J. Psychoact. Drugs"},{"key":"B47","first-page":"468","article-title":"Negative Reinforcing Properties of Some Psychotropic Drugs in Drug-Naive Rhesus Monkeys","volume":"192","author":"Hoffmeister","year":"1975","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e356","DOI":"10.1016\/S2468-2667(17)30118-4","article-title":"The Effect of Multiple Adverse Childhood Experiences on Health: a Systematic Review and Meta-Analysis","volume":"2","author":"Hughes","year":"2017","journal-title":"Lancet Public Health"},{"key":"B49","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.neuropharm.2018.01.017","article-title":"Ketamine for the Treatment of Addiction: Evidence and Potential Mechanisms","volume":"142","author":"Ivan Ezquerra-Romano","year":"2018","journal-title":"Neuropharmacology"},{"key":"B50","volume-title":"Yakama Rising: Indigenous Cultural Revitalization, Activism, and Healing","author":"Jacob","year":"2013"},{"key":"B51","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1177\/0269881114568039","article-title":"Psychedelics Not Linked to Mental Health Problems or Suicidal Behavior: A Population Study","volume":"29","author":"Johansen","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1177\/0269881108093587","article-title":"Human Hallucinogen Research: Guidelines for Safety","volume":"22","author":"Johnson","year":"2008","journal-title":"J. Psychopharmacol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1177\/0269881114548296","article-title":"Pilot Study of the 5-HT2AR Agonist Psilocybin in the Treatment of Tobacco Addiction","volume":"28","author":"Johnson","year":"2014","journal-title":"J. Psychopharmacol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3109\/00952990.2016.1170135","article-title":"Long-term Follow-Up of Psilocybin-Facilitated Smoking Cessation","volume":"43","author":"Johnson","year":"2017","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"B55","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/add.15448","article-title":"Safety of Ibogaine Administration in Detoxification of Opioid-dependent Individuals: a Descriptive Open-Label Observational Study","volume":"117","author":"Knuijver","year":"2022","journal-title":"Addiction"},{"key":"B56","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.biopsych.2014.04.010","article-title":"Psilocybin-induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers","volume":"78","author":"Kraehenmann","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"B57","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1177\/0269881112439253","article-title":"Lysergic Acid Diethylamide (LSD) for Alcoholism: Meta-Analysis of Randomized Controlled Trials","volume":"26","author":"Krebs","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/02791072.2007.10399860","article-title":"Single versus Repeated Sessions of Ketamine-Assisted Psychotherapy for People with Heroin Dependence","volume":"39","author":"Krupitsky","year":"2007","journal-title":"J. Psychoact. Drugs"},{"key":"B59","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1176\/appi.ps.201100399","article-title":"The Role of Culture in Substance Abuse Treatment Programs for American Indian and Alaska Native Communities","volume":"63","author":"Legha","year":"2012","journal-title":"Psychiatr. Serv."},{"key":"B60","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","article-title":"Psychedelics Promote Structural and Functional Neural Plasticity","volume":"23","author":"Ly","year":"2018","journal-title":"Cell. Rep."},{"key":"B61","doi-asserted-by":"publisher","first-page":"39","DOI":"10.9740\/mhc.2017.01.039","article-title":"Ayahuasca: An Ancient Sacrament for Treatment of Contemporary Psychiatric Illness?","volume":"7","author":"Malcolm","year":"2017","journal-title":"Ment. Health Clin."},{"key":"B62","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12888-018-1824-6","article-title":"Inclusion of People of Color in Psychedelic-Assisted Psychotherapy: A Review of the Literature","volume":"18","author":"Michaels","year":"2018","journal-title":"BMC psychiatry"},{"key":"B63","volume-title":"Monitoring the Future National Survey Results on Drug Use, 1975-2016: Volume I, Secondary School Students","author":"Miech","year":"2017"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/s41591-021-01336-3","article-title":"MDMA-assisted Therapy for Severe PTSD: a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study","volume":"27","author":"Mitchell","year":"2021","journal-title":"Nat. Med."},{"key":"B65","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1007\/s00213-019-05249-5","article-title":"MDMA-assisted Psychotherapy for Treatment of PTSD: Study Design and Rationale for Phase 3 Trials Based on Pooled Analysis of Six Phase 2 Randomized Controlled Trials","volume":"236","author":"Mithoefer","year":"2019","journal-title":"Psychopharmacol. Berl."},{"key":"B66","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40352-017-0056-z","article-title":"The Development of a Healing Model of Care for an Indigenous Drug and Alcohol Residential Rehabilitation Service: a Community-Based Participatory Research Approach","volume":"5","author":"Munro","year":"2017","journal-title":"Health Justice"},{"key":"B67","unstructured":"New Mexico: Opioid-Involved Deaths and Related Harms2020"},{"key":"B68","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1055\/a-1524-2794","article-title":"Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, Is Associated with Seizures: an Analysis of Online Psychedelic Experience Reports","volume":"54","author":"Nayak","year":"2021","journal-title":"Pharmacopsychiatry"},{"key":"B69","unstructured":"New Mexico Substance Use Epidemiology Profile2021"},{"key":"B70","unstructured":"Adverse Childhood Experiences Among NM Adults: Results from the NM BRFSS 20192021"},{"key":"B71","unstructured":"Substance Use Disorder Treatment and Outcomes in New Mexico2019"},{"key":"B72","unstructured":"2019 Veterans Profile2019"},{"key":"B73","doi-asserted-by":"publisher","first-page":"2045125320986634","DOI":"10.1177\/2045125320986634","article-title":"Within-treatment Changes in a Novel Addiction Treatment Program Using Traditional Amazonian Medicine","volume":"11","author":"O'Shaughnessy","year":"2021","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.863552","article-title":"Using a MDMA-And LSD-Group Therapy Model in Clinical Practice in Switzerland and Highlighting the Treatment of Trauma-Related Disorders","volume":"739","author":"Oehen","year":"2022","journal-title":"Front. Psychiatry"},{"key":"B75","doi-asserted-by":"publisher","first-page":"108710","DOI":"10.1016\/j.jsat.2021.108710","article-title":"Healthcare Coverage and Service Access for Low-Income Adults with Substance Use Disorders","volume":"137","author":"Olfson","year":"2021","journal-title":"J. Subst. Abuse Treat."},{"key":"B76","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.2105\/AJPH.2021.306486","article-title":"Trends in Ketamine Use, Exposures, and Seizures in the united states up to 2019","volume":"111","author":"Palamar","year":"2021","journal-title":"Am. J. Public Health"},{"key":"B77","doi-asserted-by":"publisher","first-page":"2050324518767442","DOI":"10.1177\/2050324518767442","article-title":"The Early Use of MDMA (\u2018Ecstasy\u2019) in Psychotherapy (1977\u20131985)","volume":"4","author":"Passie","year":"2018","journal-title":"Drug Sci. Policy Law"},{"key":"B78","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1177\/107327480801500310","article-title":"Establishing Trusting Partnerships for Successful Recruitment of American Indians to Clinical Trials","volume":"15","author":"Petereit","year":"2008","journal-title":"Cancer control."},{"key":"B79","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/ijnp\/pyx047","article-title":"Effect of Psilocybin on Empathy and Moral Decision-Making","volume":"20","author":"Pokorny","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4103\/2542-3932.211589","article-title":"Trauma Interventions Using Mindfulness Based Extinction and Reconsolidation (TIMBER) Psychotherapy Prolong the Therapeutic Effects of Single Ketamine Infusion on Post-traumatic Stress Disorder and Comorbid Depression: a Pilot Randomized, Placebo-Controlled, Crossover Clinical Trial","volume":"2","author":"Pradhan","year":"2017","journal-title":"Asia Pac J. Clin. Trials Nerv. Syst. Dis."},{"key":"B81","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/j.1521-0391.2013.12083.x","article-title":"Prevalence of Reported Peyote Use 1985-2010 Effects of the American Indian Religious Freedom Act of 1994","volume":"23","author":"Prue","year":"2014","journal-title":"Am. J. Addict."},{"key":"B82","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1111\/jgs.16032","article-title":"Associations of Adverse Childhood Experiences with Past-Year DSM-5 Psychiatric and Substance Use Disorders in Older Adults","volume":"67","author":"Rhee","year":"2019","journal-title":"J. Am. Geriatr. Soc."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1177\/0269881119855974","article-title":"Emotional Breakthrough and Psychedelics: Validation of the Emotional Breakthrough Inventory","volume":"33","author":"Roseman","year":"2019","journal-title":"J. Psychopharmacol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1177\/0269881121991792","article-title":"First Study of Safety and Tolerability of 3,4-Methylenedioxymethamphetamine-Assisted Psychotherapy in Patients with Alcohol Use Disorder","volume":"35","author":"Sessa","year":"2021","journal-title":"J. Psychopharmacol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.addbeh.2017.11.020","article-title":"Patterns of Adverse Childhood Experiences and Substance Use Among Young Adults: A Latent Class Analysis","volume":"78","author":"Shin","year":"2018","journal-title":"Addict. Behav."},{"key":"B86","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/ajcp.12354","article-title":"Partnering with Native Communities to Develop a Culturally Grounded Intervention for Substance Use Disorder","volume":"64","author":"Skewes","year":"2019","journal-title":"Am. J. Community Psychol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1080\/10508420903274971","article-title":"Community-based Participatory Research for Improved Mental Health","volume":"19","author":"Smikowski","year":"2009","journal-title":"Ethics Behav."},{"key":"B88","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1177\/0269881116628430","article-title":"Decreased Mental Time Travel to the Past Correlates with Default-Mode Network Disintegration under Lysergic Acid Diethylamide","volume":"30","author":"Speth","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"CD002795","DOI":"10.1002\/14651858.CD002795.pub2","article-title":"Pharmacotherapy for Post Traumatic Stress Disorder (PTSD)","volume":"2006","author":"Stein","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"B90","volume-title":"DMT: The Spirit Molecule: A Doctor's Revolutionary Research into the Biology of Near-Death and Mystical Experiences","author":"Strassman","year":"2000"},{"key":"B91","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0166-4328(96)00081-2","article-title":"Human Psychopharmacology of N,N-dimethyltryptamine","volume":"73","author":"Strassman","year":"1995","journal-title":"Behav. Brain Res."},{"key":"B92","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/0006-3223(95)00200-6","article-title":"Differential Tolerance to Biological and Subjective Effects of Four Closely Spaced Doses of N,N-dimethyltryptamine in Humans","volume":"39","author":"Strassman","year":"1996","journal-title":"Biol. Psychiatry"},{"key":"B93","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1001\/archpsyc.1994.03950020009001","article-title":"Dose-response Study of N,N-dimethyltryptamine in Humans. I. Neuroendocrine, Autonomic, and Cardiovascular Effects","volume":"51","author":"Strassman","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"B94","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1001\/archpsyc.1994.03950020022002","article-title":"Dose-response Study of N,N-dimethyltryptamine in Humans. II. Subjective Effects and Preliminary Results of a New Rating Scale","volume":"51","author":"Strassman","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"B95","unstructured":"DEA Hearing on Scheduling of MDMA Under the Controlled Substances Act\n            Testimony of George Greer\n          1984"},{"key":"B96","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2174\/15733998113099990003","article-title":"Ayahuasca-assisted Therapy for Addiction: Results from a Preliminary Observational Study in Canada","volume":"6","author":"Thomas","year":"2013","journal-title":"Curr. Drug Abuse Rev."},{"key":"B97","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.addbeh.2018.05.017","article-title":"Future Directions for Medication Assisted Treatment for Opioid Use Disorder with American Indian\/Alaska Natives","volume":"86","author":"Venner","year":"2018","journal-title":"Addict. Behav."},{"key":"B98","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/eahr.500090","article-title":"American Indian and Alaska Native Enrollment in Clinical Studies in the National Institutes of Health's Intramural Research Program","volume":"43","author":"Vigil","year":"2021","journal-title":"Ethics &amp; Hum. Res."},{"key":"B99","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3389\/fnbeh.2018.00258","article-title":"Treating PTSD: A Review of Evidence-Based Psychotherapy Interventions","volume":"12","author":"Watkins","year":"2018","journal-title":"Front. Behav. Neurosci."},{"key":"B100","first-page":"238","article-title":"Gaps in Clinical Prevention and Treatment for Alcohol Use Disorders: Costs, Consequences, and Strategies","volume":"35","author":"Willenbring","year":"2014","journal-title":"Alcohol Res."},{"key":"B101","doi-asserted-by":"publisher","first-page":"108071","DOI":"10.1016\/j.drugalcdep.2020.108071","article-title":"Trends in LSD Use Among US Adults: 2015-2018","volume":"212","author":"Yockey","year":"2020","journal-title":"Drug Alcohol Depend."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.905753\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T02:02:06Z","timestamp":1656295326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.905753\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,27]]},"references-count":101,"alternative-id":["10.3389\/fphar.2022.905753"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.905753","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,27]]},"article-number":"905753"}}